Iterion Therapeutics Adds Manuel Aivado and Bob Smith as Tegavivint Pipeline Expands

Wednesday, August 12, 2026Sobeida DiloneView original
Iterion Therapeutics Adds Manuel Aivado and Bob Smith as Tegavivint Pipeline Expands

Iterion Therapeutics has appointed Manuel Aivado, MD, PhD, and Bob Smith as independent directors, adding clinical development, pharmaceutical partnering and... Read More

The post Iterion Therapeutics Adds Manuel Aivado and Bob Smith as Tegavivint Pipeline Expands appeared first on citybiz.